BPG is committed to discovery and dissemination of knowledge
Clinical Research
©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 1090-1093
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.1090
Figure 3
Figure 3 ESL using Speedband, Superview multiple band ligator (Boston Scientific Co. , Watertown, MA) and sclero-therapy needle. (A) EVL at least 5 cm or more proximal to gastroesopahgeal junction, (B) sclerotherapy 2 to 3 cm proximal to gastroesophageal junction on the same varix, (C) EVL on the injection site (arrow) and (D) proximal (large arrow) and distal (small arrow) EVL on the same varix.


Write to the Help Desk